AT

Advent Therapeutics

PA - Doylestown
Biotechnology1 H-1B visas (FY2023)

Focus: Retinol Palmitate for Prevention of Bronchopulmonary Dysplasia in Premature Infants

Advent Therapeutics is a life sciences company focused on Retinol Palmitate for Prevention of Bronchopulmonary Dysplasia in Premature Infants.

Respiratory
Funding Stage
PUBLIC
Open Jobs
0

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts
H-1B (2023): 1 approval

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub